Autologous haemopoietic stem cell transplantation for autoimmune diseases (Q37879139)

24 August 2017

1 reference

title

Autologous haemopoietic stem cell transplantation for autoimmune diseases (English)

1 reference

stem cell transplantation

24 August 2017

main subject

1 reference

3

Peter Szodoray

1 reference

24 August 2017

Margit Zeher

1

1 reference

24 August 2017

Gabor Papp

series ordinal

2

1 reference

24 August 2017

language of work or name

English

0 references

publication date

24 May 2011

1 reference

Expert Opinion on Biological Therapy

24 August 2017

published in

1 reference

24 August 2017

volume

11

1 reference

24 August 2017

issue

9

1 reference

24 August 2017

page(s)

1193-1201

1 reference

New concepts on the pathogenesis of autoimmune diseases: a role for immune homeostasis, immunoregulation, and immunosenescence

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517/14712598.2011.580272

Novel targeted therapies for autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.2011.580272

Treatment of severe autoimmune disease by stem-cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.2011.580272

Autologous stem cell transplantation in autoimmune and rheumatic diseases: from the molecular background to clinical applications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.2011.580272

Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.2011.580272

Autologous hematopoietic stem cell transplantation for autoimmune diseases: an observational study on 12 years' experience from the European Group for Blood and Marrow Transplantation Working Party on Autoimmune Diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.2011.580272

Cardiovascular disease complications in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.2011.580272

Nonmyeloablative hematopoietic stem cell transplantation for systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.2011.580272

The role of immune ablation and stem cell transplantation in severe SLE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.2011.580272

Hematopoietic stem cell transplantation for systemic lupus erythematosus, the antiphospholipid syndrome and bullous skin diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.2011.580272

Scleroderma: from cell and molecular mechanisms to disease models

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.2011.580272

The pronounced Th17 profile in systemic sclerosis (SSc) together with intracellular expression of TGFbeta and IFNgamma distinguishes SSc phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.2011.580272

Autologous stem cell transplantation in the treatment of systemic sclerosis: report from the EBMT/EULAR Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.2011.580272

Allogeneic marrow transplantation in patients with severe systemic sclerosis: resolution of dermal fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.2011.580272

High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: long-term follow-up of the US multicenter pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.2011.580272

Phenotypic characterization of autoreactive T cells in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.2011.580272

Stem cell transplantation in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.2011.580272

Autologous stem-cell transplantation in malignant multiple sclerosis: a case with a favorable long-term outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.2011.580272

Autologous non-myeloablative haemopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: a phase I/II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.2011.580272

Early highly aggressive MS successfully treated by hematopoietic stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.2011.580272

Haematopoietic stem cell transplantation in the treatment of severe autoimmune disease: results from phase I/II studies, prospective randomized trials and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.2011.580272

Autologous stem cell transplantation in autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.2011.580272

Stem cell transplantation for autoimmune disorders. Refractory juvenile idiopathic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.2011.580272

Haematopoietic stem cell transplantation for vasculitis including Behcet's disease and polychondritis: a retrospective analysis of patients recorded in the European Bone Marrow Transplantation and European League Against Rheumatism databases and a r

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.2011.580272

Autologous non-myeloablative haematopoietic stem cell transplantation for refractory systemic vasculitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.2011.580272

Autologous haematopoietic stem cell transplantation for Behcet's disease with pulmonary involvement: analysis after 5 years of follow up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.2011.580272

Use of rituximab for refractory cytopenias associated with autoimmune lymphoproliferative syndrome (ALPS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.2011.580272

Overview of stem cell therapy for Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.2011.580272

Autologous haematopoietic stem cell transplantation without CD34 cell selection in refractory Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.2011.580272

Successful autologous stem cell transplantation in a patient with chronic inflammatory demyelinating polyneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.2011.580272

Genetics, pathogenesis and clinical interventions in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.2011.580272

Autologous hematopoietic stem cell transplantation for childhood autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.2011.580272

Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.2011.580272

C-peptide levels and insulin independence following autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.2011.580272

Randomized controlled trials of autologous hematopoietic stem cell transplantation for autoimmune diseases: the evolution from myeloablative to lymphoablative transplant regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.2011.580272

Autoimmune disease after autologous hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.2011.580272

Evaluation of the risk of therapy-related MDS/AML after autologous stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.2011.580272

High-dose cyclophosphamide with stem cell rescue for severe rheumatoid arthritis: Short-term efficacy correlates with reduction of macroscopic and histologic synovitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.2011.580272

10.1517/14712598.2011.580272

21 January 2018

Identifiers

DOI

1 reference

24 August 2017

1 reference